Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.341
-0.102 (-22.99%)
At close: Jun 26, 2026, 4:00 PM EDT
0.350
+0.009 (2.64%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Jasper Therapeutics Employees
Jasper Therapeutics had 22 employees as of December 31, 2025. The number of employees decreased by 42 or -65.63% compared to the previous year.
Employees
22
Change (1Y)
-42
Growth (1Y)
-65.63%
Revenue / Employee
n/a
Profits / Employee
-$2,533,364
Market Cap
9.55M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22 | -42 | -65.63% |
| Dec 31, 2024 | 64 | 19 | 42.22% |
| Dec 31, 2023 | 45 | 10 | 28.57% |
| Dec 31, 2022 | 35 | 10 | 40.00% |
| Dec 31, 2021 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| BioLineRx | 24 |
| BioCardia | 21 |
| IN8bio | 18 |
| SeaStar Medical Holding | 17 |
| BioVie | 13 |
| Cocrystal Pharma | 10 |
| Traws Pharma | 7 |
JSPR News
- 12 days ago - Jasper Therapeutics Proxy statement: Proxy filing - Filings
- 12 days ago - Jasper Therapeutics Proxy statement: Proxy filing - Filings
- 26 days ago - Jasper Therapeutics initiates review of strategic alternatives - TheFly
- 26 days ago - Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value - GlobeNewsWire
- 6 weeks ago - Jasper Therapeutics price target lowered to $3 from $4 at RBC Capital - TheFly
- 6 weeks ago - Jasper Therapeutics downgraded to Hold from Buy at TD Cowen - TheFly
- 6 weeks ago - Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Jasper Therapeutics Quarterly report: Q1 2026 - Filings